Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Open Access
- 1 January 2011
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 4, 38
- https://doi.org/10.3389/fnmol.2011.00038
Abstract
Brain dopamine receptors have been prefered targets for numerous pharmacological compounds developed for the treatment of various neuropsychiatric disorders. Recent discovery that D2 dopamine receptors, in addition to cAMP pathways, can engage also in Akt/GSK3 signaling cascade provided a new framework to understand intracellular signaling mechanisms involved in dopamine-related behaviors and pathologies. Here we review a recent progress in understanding the role of Akt, GSK3 and related signaling molecules in dopamine receptor signaling and functions. Particularly, we focus on the molecular mechanisms involved, interacting partners, role of these signaling events in the action of antipsychotics, psychostimulants and antidepressants as well as involvement in pathophysiology of schizophrenia, bipolar disorder and Parkinson’s disease. Further understanding of the role of Akt/GSK3 signaling in dopamine receptor functions could provide novel targets for pharmacological interventions in dopamine-related disorders.Keywords
This publication has 99 references indexed in Scilit:
- DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212Neuron, 2009
- Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1Trends in Neurosciences, 2009
- Cocaine-induced hyperactivity and sensitization are dependent on GSK3Neuropharmacology, 2009
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporterCellular Signalling, 2009
- Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out miceBehavioural Brain Research, 2008
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008
- The role of GSK‐3 in synaptic plasticityBritish Journal of Pharmacology, 2008
- PI3 kinase/Akt activation mediates estrogen and IGF‐1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's diseaseDevelopmental Neurobiology, 2008
- A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex developmentNature, 2005